CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
Homologous Recombination
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 1, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
Angelika Gründling1, Quanjiang Ji2, Stephen J Salipante3
1Section of Molecular Microbiology and Medical Research Council Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, United Kingdom a.grundling@imperial.ac.uk quanjiangji@shanghaitech.edu.cn stevesal@uw.edu.
This article reviews modern genetic engineering tools for Staphylococcus aureus, focusing on systems that use the CRISPR-Cas9 protein to modify DNA more efficiently than traditional methods. It explains how researchers can delete genes, change specific DNA letters, or turn off gene function using modified versions of the Cas9 enzyme. These advanced techniques provide powerful ways to study how this bacterium survives and causes disease.
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Area of Science:
Background:
Traditional approaches for modifying bacterial DNA often rely on slow allelic exchange procedures. This limitation creates a significant hurdle for researchers studying complex genetic traits in pathogens. Recent advancements have introduced faster, more precise alternatives for manipulating microbial genomes. These newer strategies leverage the programmable nature of RNA-guided nucleases. Scientists now possess tools that bypass the labor-intensive requirements of older genetic manipulation protocols. That uncertainty drove the development of specialized plasmid systems tailored for specific bacterial hosts. No prior work had resolved the efficiency issues inherent in standard chromosomal editing workflows. This paper addresses how these modern systems transform the landscape of bacterial genetic engineering.
Purpose Of The Study:
The aim of this review is to describe modern CRISPR-Cas9-based systems for genome editing in Staphylococcus aureus. Researchers seek to overcome the limitations associated with traditional, time-consuming allelic exchange methods. This work explains how specialized plasmid systems facilitate rapid gene mutation and inactivation. The authors address the need for more efficient tools to study bacterial gene function. They investigate how different Cas9 variants enable diverse types of genetic alterations. The study explores the integration of counterselection and recombineering for gene deletion. It also examines the use of nCas9-deaminase fusions for precise base editing. This overview provides a clear understanding of the current technological landscape for manipulating this important pathogen.
Main Methods:
This review approach evaluates the implementation of specialized plasmid-based systems for genetic modification. The authors examine how counterselection strategies integrate with recombineering to facilitate chromosomal deletions. They analyze the structural differences between dead Cas9 and Cas9 nickase variants. The investigation covers the fusion of nCas9 with various nucleoside deaminases for precise nucleotide alterations. The authors assess the application of these enzymes in silencing gene expression through codon modification. The review synthesizes data regarding the efficiency of these tools in bacterial environments. The authors compare these modern techniques against established allelic exchange protocols. This synthesis provides a comprehensive overview of current genetic engineering capabilities for this organism.
Main Results:
Key findings from the literature indicate that CRISPR-Cas9 systems significantly improve the speed of chromosomal mutations. The authors report that combining counterselection with recombineering enables successful targeted gene deletions. The data demonstrate that nCas9-deaminase fusions facilitate specific base changes within target genes. The results show that these fusion enzymes effectively introduce premature stop codons to achieve gene inactivation. The findings confirm that mutating start codons serves as a reliable method for silencing gene function. The literature suggests that these tools offer greater precision than traditional allelic exchange methods. The authors observe that these systems provide a versatile platform for diverse genetic manipulations. The evidence highlights the potential of these methods to streamline functional genomic research in this bacterium.
Conclusions:
The authors synthesize how CRISPR-Cas9 systems offer a robust framework for rapid genetic modification. These tools enable precise chromosomal alterations that were previously difficult to achieve. The review highlights the versatility of nCas9-deaminase fusions for site-specific base editing. Such methods allow for the introduction of premature stop codons to silence gene expression effectively. Researchers can also manipulate start codons to achieve targeted gene inactivation. The evidence suggests that these systems significantly accelerate the pace of functional genomic studies. These findings underscore the broad utility of programmable nucleases in modern microbiology. The authors conclude that these strategies represent a major shift in how scientists approach bacterial genome manipulation.
The researchers propose using a CRISPR-Cas9 counterselection strategy paired with recombineering. This combination facilitates the efficient deletion of specific DNA segments within the bacterial chromosome, providing a faster alternative to traditional allelic exchange protocols.
The authors introduce dead Cas9 (dCas9) and Cas9 nickase (nCas9) enzymes. These modified proteins serve as the foundation for various editing applications, including base changes and gene silencing, by leveraging their ability to bind or nick DNA without creating double-strand breaks.
A nCas9 enzyme fused to nucleoside deaminases is necessary to introduce precise base changes. This fusion protein enables researchers to target specific nucleotides for conversion, allowing for the creation of point mutations within the bacterial genome.
The nCas9-deaminase fusion enzymes play a role in targeted gene inactivation. By introducing premature stop codons or altering start codons, these tools effectively turn off gene function, which is essential for determining the biological role of specific bacterial genes.
The authors discuss the introduction of premature stop codons or the mutation of start codons as specific measurements of gene inactivation. These modifications ensure that the target gene product is either truncated or never produced, confirming the successful silencing of the gene.
The authors imply that these CRISPR-Cas9-based methods possess significant power for genome editing. They suggest that these tools provide a more efficient and versatile approach compared to older techniques, potentially accelerating functional studies in this pathogen.